Qlt Inc (QLTI): Broadfin’s Kevin Kotler to Become Director of Novelion

Page 2 of 8 – SEC Filing
CUSIP No.
746927102
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Broadfin Capital, LLC
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
[_]
(b)
[x]
3.
SEC USE ONLY
4.
SOURCE OF FUNDS
AF, WC
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
[_]
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7.
SOLE VOTING POWER
0
8.
SHARED VOTING POWER
4,445,527
9.
SOLE DISPOSITIVE POWER
0
10.
SHARES DISPOSITIVE POWER
[_]
4,445,527
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,445,527
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.41%
14.
TYPE OF REPORTING PERSON
OO

Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)